Cypress Bioscience, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cypress Bioscience, Inc.
FTC and DoJ issue guidance for businesses working together to tackle coronavirus pandemic; BIO is 'pleased' they intend to help facilitate critical partnerships.
In addition to our daily in-depth coverage of key events relating to the coronavirus pandemic, we’re bringing you a periodic round-up of other significant developments.
Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug
As the global number of COVID-19 cases exceeds 500,000 for the first time, more biopharma companies throw their weight behind Gates Foundation's drug-hunting initiative.
Roche announced that the US FDA has granted an Emergency Use Authorization for the cobas SARS-CoV-2 test for patients suspected to have COVID-19. bioMérieux is planning three COVID-19 tests.
- Medical Devices
In Vitro Diagnostics
- Therapeutic Drug Monitoring
- Other Names / Subsidiaries
- Cellatope Corporation
- Proprius Pharmaceuticals, Inc., Ramius LLC
- Royalty Pharma